6/2018
vol. 35
abstract:
Original paper
Impact of low-level laser therapy on the dynamics of pressure ulcer-induced changes considering an infectious agent and cathelicidin LL-37 concentration: a preliminary study
Małgorzata Brauncajs, Krzysztof Ksiąszczyk, Anna Lewandowska-Polak, Katarzyna Gorzela, Janina Grzegorczyk
Adv Dermatol Allergol 2018; XXXV (6): 582-586
Online publish date: 2018/08/13
Introduction Low-level laser therapy is used in managing chronic wounds including pressure ulcers. Less is known about its impact on the healing process if an inhibitive agent e.g. bacterial infection takes place. Modulating non-specific immunity processes might eliminate bacteria if laser therapy is applied.
Aim To investigate the impact of low-level laser therapy on pressure ulcer dynamics considering an infectious agent and cathelicidin LL-37 concentration.
Material and Methods The study comprised 6 patients with pressure ulcers ranging from stage II to III in Torrance classification and 12 patients without pressure ulcers. Venous blood sample and decubitus wound swab were taken – in study groups A at baseline and after 2 weeks; in control group B once – at a specific point of time. The swabs served for species identification. Drug susceptibility of isolated pathogens and cathelicidin LL-37 in serum concentration were measured.
Results In study group A, the following bacteria predominantly occurred: S. aureus, E. faecalis, P. mirabilis, P. aeruginosa, while in control group B, excluding one MRSA case, S. hominis, S. epidermidis, D. nishinomiyaensis, A. haemolyticus (physiological flora) were present. HLGR resistance mechanisms were detected when analyzing drug susceptibility panels. Study group A findings demonstrated a statistically significant difference between the levels of cathelicidin LL-37 concentration at baseline and at the end.
Conclusions There is insufficient information to accurately determine the effect of LLLT on pressure ulcer dynamics considering an infectious agent. These effects may occur if innate immunity processes are modulated so that laser therapy might eliminate bacteria indirectly.
keywords:
pressure ulcers, low-level laser therapy
references:
Atkinson A, Campbell K, Dolynchuk K, et al. Best practices for the prevention and treatment of pressure ulcers. Ostomy Wound Manage 2000; 46: 38-52.
Hirasawa T, Ishihara M, Kushibiki T, et al. Regulation of
miRNA expression by low-level laser therapy (LLLT) and photodynamic therapy (PDT). Int J Mol Sci 2013; 14: 13542-58.
Basso FG, Hebling J, Kurachi C, et al. Biostimulatory effect of low-level laser therapy on keratinocytes in vitro. Lasers Med Sci 2013; 28: 367-74.
Bayat M, Ezzati A, Mohsenifar Z, et al. Low-level laser therapy with pulsed infrared laser accelerates third-degree burn healing process in rats. J Rehabil Res Develop 2009; 46: 543-54.
Houreld NN, Nteleki B. The use of phototherapy in the treatment of diabetic ulcers. J Endocrinol Metabol Diabetes South Africa 2012; 17: 128-32.
Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 1998; 176 Suppl. 2 A: 26-38.
Szymczyszyn A, Doroszko A, Szahidewicz-Krupska E, et al. Effects of transdermal low-level laser therapy on endothelial function. Lasers Med Sci 2016; 31: 1301-7.
Chromek M. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 2006; 12: 636-41.
Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-95.
Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-20.
Fukuda TY, Sato MN, Silva SR, et al. Infrared low-level diode laser on inflammatory process modulation in mice: pro- and anti-inflammatory cytokines. Lasers Med Sci 2013; 28: 1305-13.
Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004; 75: 39-48.
Thai TP, Houghton PE, Campbell KE, et al. Ultraviolet light C in the treatment of chronic wounds with MRSA: a case study. Ostomy Wound Manage 2002; 48: 52-60.
Bayat M, Jalili MR, Razavie N, et al. Effects of low-level laser therapy on mast cell number and degranulation in third-degree burns of rats. J Rehabil Res Develop 2008; 45: 931-8.
Barbosa Pinheiro AL, Cavalcanti de Sousa AP, Matos Paraguassu G, et al. Laser and LED phototherapies on angiogenesis. Lasers Med Sci 2013; 28: 981-7.
|
|